ASCO 2022: Latest in prostate cancer, including PARP inhibitors from parp Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 16 min 96 sec ✓ Published: 06-Jun-2022
Description: Dr Neal Shore (Carolina Urologic Research Center, Myrtle Beach, USA), Prof Phil Cornford (Royal Liverpool University Hospital, Liverpool, UK), Prof Eleni Efstathiou (Houston Methodist Cancer Center, Houston, USA) and Prof Cora Sternberg (Weill Cornell Medicine, New York, USA) discuss the latest in prostate cancer, including PARP inhibitors. nnInitially, they discuss the latest trials and updates in prostate cancer including PROPEL, MAGNITUDE and the ARCHES trial.nnThey discuss the use of Lutetiu
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)